Cited 0 time in
Monoclonal Antibodies-A New Horizon in Alzheimer's Treatment
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kwon, Hyuk Sung | - |
| dc.contributor.author | Koh, Seong-Ho | - |
| dc.date.accessioned | 2025-02-12T06:01:26Z | - |
| dc.date.available | 2025-02-12T06:01:26Z | - |
| dc.date.issued | 2025-01 | - |
| dc.identifier.issn | 1738-6586 | - |
| dc.identifier.issn | 2005-5013 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/206434 | - |
| dc.description.abstract | [No abstract available] | - |
| dc.format.extent | 2 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 대한신경과학회 | - |
| dc.title | Monoclonal Antibodies-A New Horizon in Alzheimer's Treatment | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.3988/jcn.2024.0527 | - |
| dc.identifier.scopusid | 2-s2.0-85215802384 | - |
| dc.identifier.wosid | 001390890400001 | - |
| dc.identifier.bibliographicCitation | Journal of Clinical Neurology, v.21, no.1, pp 1 - 2 | - |
| dc.citation.title | Journal of Clinical Neurology | - |
| dc.citation.volume | 21 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 2 | - |
| dc.type.docType | Editorial Material | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
| dc.subject.keywordPlus | Alzheimer disease | - |
| dc.subject.keywordPlus | amyloid related imaging abnormality | - |
| dc.subject.keywordPlus | antibody therapy | - |
| dc.subject.keywordPlus | brain hemorrhage | - |
| dc.subject.keywordPlus | caregiver | - |
| dc.subject.keywordPlus | cerebral macrohemorrhage | - |
| dc.subject.keywordPlus | Clinical Dementia Rating Sum of Boxes | - |
| dc.subject.keywordPlus | clinical trial (topic) | - |
| dc.subject.keywordPlus | disease burden | - |
| dc.subject.keywordPlus | disease exacerbation | - |
| dc.subject.keywordPlus | disease severity | - |
| dc.subject.keywordPlus | drug cost | - |
| dc.subject.keywordPlus | Editorial | - |
| dc.subject.keywordPlus | health care cost | - |
| dc.subject.keywordPlus | health care system | - |
| dc.subject.keywordPlus | human | - |
| dc.subject.keywordPlus | imaging | - |
| dc.subject.keywordPlus | nervous system inflammation | - |
| dc.subject.keywordPlus | nuclear magnetic resonance imaging | - |
| dc.subject.keywordPlus | risk factor | - |
| dc.subject.keywordPlus | scoring system | - |
| dc.identifier.url | https://thejcn.com/DOIx.php?id=10.3988/jcn.2024.0527 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
